EE566 Cost-Effectiveness and Budget Impact Analysis of Selective Internal Radiation Therapy Versus Atezolizumab Plus Bevacizumab From a German Statutory Health Insurance Perspective

Autor:	B Schwander, K Klesper, S Rossol, K Herrmann, YF Zoellner
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S167
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.806
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::92a39e91fc7f9ae79685632014b34e97 https://doi.org/10.1016/j.jval.2022.09.806 Zobrazit plný text záznamu Full Text from ScienceDirect